-
1
-
-
79953027576
-
Challenges in inhaled product development and opportunities for open innovation
-
1:CAS:528:DC%2BC3MXjvV2ktro%3D 21144875
-
Forbes B, Asgharian B, Dailey LA, Ferguson D, Gerde P, Gumbleton M, et al. Challenges in inhaled product development and opportunities for open innovation. Adv Drug Deliv Rev. 2011;63(1-2):69-87.
-
(2011)
Adv Drug Deliv Rev
, vol.63
, Issue.1-2
, pp. 69-87
-
-
Forbes, B.1
Asgharian, B.2
Dailey, L.A.3
Ferguson, D.4
Gerde, P.5
Gumbleton, M.6
-
2
-
-
84946477948
-
Principles and practice of pulmonary drug delivery
-
A.S. Narang R.I. Mahato (eds) CRC Press Boca Raton
-
Gupta V, Thomas C, Ahsan F. Principles and practice of pulmonary drug delivery. In: Narang AS, Mahato RI, editors. Targeted delivery of small and macromolecular drugs. Boca Raton: CRC Press; 2010. p. 371-419.
-
(2010)
Targeted Delivery of Small and Macromolecular Drugs
, pp. 371-419
-
-
Gupta, V.1
Thomas, C.2
Ahsan, F.3
-
3
-
-
77953247048
-
Pulmonary drug delivery: Medicines for inhalation
-
M. Schäfer-Korting (eds) Springer Berlin
-
Henning A, Hein S, Schneider M, Bur M, Lehr CM. Pulmonary drug delivery: medicines for inhalation. In: Schäfer-Korting M, editor. Drug delivery. Handbook of experimental pharmacology. 197. Berlin: Springer; 2010. p. 171-92.
-
(2010)
Drug Delivery. Handbook of Experimental Pharmacology. 197
, pp. 171-192
-
-
Henning, A.1
Hein, S.2
Schneider, M.3
Bur, M.4
Lehr, C.M.5
-
4
-
-
0025152191
-
The absorption and metabolism of xenobiotics in the lung
-
1:CAS:528:DyaK3MXhs12ksQ%3D%3D
-
Taylor G. The absorption and metabolism of xenobiotics in the lung. Adv Drug Deliv Rev. 1990;5(1-2):37-61.
-
(1990)
Adv Drug Deliv Rev
, vol.5
, Issue.1-2
, pp. 37-61
-
-
Taylor, G.1
-
5
-
-
33749128073
-
Drug-induced phospholipidosis: Issues and future directions
-
1:CAS:528:DC%2BD28XmslSksL8%3D 16774494
-
Reasor MJ, Hastings KL, Ulrich RG. Drug-induced phospholipidosis: issues and future directions. Expert Opin Drug Saf. 2006;5(4):567-83.
-
(2006)
Expert Opin Drug Saf
, vol.5
, Issue.4
, pp. 567-583
-
-
Reasor, M.J.1
Hastings, K.L.2
Ulrich, R.G.3
-
6
-
-
0016260069
-
Commentary. Lysosomotropic agents
-
4606365
-
de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, Van Hoof F. Commentary. Lysosomotropic agents. Biochem Pharmacol. 1974;23(18):2495-531.
-
(1974)
Biochem Pharmacol
, vol.23
, Issue.18
, pp. 2495-2531
-
-
De Duve, C.1
De Barsy, T.2
Poole, B.3
Trouet, A.4
Tulkens, P.5
Van Hoof, F.6
-
7
-
-
84879343782
-
Intracellular drug concentrations and transporters: Measurement, modeling, and implications for the liver
-
3898878 1:CAS:528:DC%2BC3sXpvVOrtb4%3D 23588320
-
Chu X, Korzekwa K, Elsby R, Fenner K, Galetin A, Lai Y, et al. Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver. Clin Pharmacol Ther. 2013;94(1):126-41.
-
(2013)
Clin Pharmacol Ther
, vol.94
, Issue.1
, pp. 126-141
-
-
Chu, X.1
Korzekwa, K.2
Elsby, R.3
Fenner, K.4
Galetin, A.5
Lai, Y.6
-
8
-
-
84864031724
-
Drug-drug interactions involving lysosomes: Mechanisms and potential clinical implications
-
1:CAS:528:DC%2BC38XhtVOjtbjK 22616667
-
Logan R, Funk RS, Axcell E, Krise JP. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications. Expert Opin Drug Metab Toxicol. 2012;8(8):943-58.
-
(2012)
Expert Opin Drug Metab Toxicol
, vol.8
, Issue.8
, pp. 943-958
-
-
Logan, R.1
Funk, R.S.2
Axcell, E.3
Krise, J.P.4
-
9
-
-
84885856731
-
Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes
-
1:CAS:528:DC%2BC3sXhtlWjtb3L 23970383
-
Logan R, Kong A, Krise JP. Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes. J Pharm Sci. 2013;102(11):4173-80.
-
(2013)
J Pharm Sci
, vol.102
, Issue.11
, pp. 4173-4180
-
-
Logan, R.1
Kong, A.2
Krise, J.P.3
-
10
-
-
17644371419
-
Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions
-
1:CAS:528:DC%2BD2MXitlKgtLw%3D 15828758
-
Chen Y, Walsh RJ, Arriaga EA. Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions. Anal Chem. 2005;77(8):2281-7.
-
(2005)
Anal Chem
, vol.77
, Issue.8
, pp. 2281-2287
-
-
Chen, Y.1
Walsh, R.J.2
Arriaga, E.A.3
-
11
-
-
28544452083
-
A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict
-
1:CAS:528:DC%2BD2MXpvFaiurs%3D 16323951
-
Duvvuri M, Krise JP. A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict. Mol Pharm. 2005;2(6):440-8.
-
(2005)
Mol Pharm
, vol.2
, Issue.6
, pp. 440-448
-
-
Duvvuri, M.1
Krise, J.P.2
-
12
-
-
84884648979
-
Subcellular distribution of azithromycin and clarithromycin in rat alveolar macrophages (NR8383) in vitro
-
1:CAS:528:DC%2BC3sXhslSqtrnN 23995662
-
Togami K, Chono S, Morimoto K. Subcellular distribution of azithromycin and clarithromycin in rat alveolar macrophages (NR8383) in vitro. Biol Pharm Bull. 2013;36(9):1494-9.
-
(2013)
Biol Pharm Bull
, vol.36
, Issue.9
, pp. 1494-1499
-
-
Togami, K.1
Chono, S.2
Morimoto, K.3
-
13
-
-
84860725460
-
Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: Implications for an intracellular distribution-based drug interaction
-
3348458 1:CAS:528:DC%2BC38XksVymt7Y%3D 22449202
-
Funk RS, Krise JP. Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction. Mol Pharm. 2012;9(5):1384-95.
-
(2012)
Mol Pharm
, vol.9
, Issue.5
, pp. 1384-1395
-
-
Funk, R.S.1
Krise, J.P.2
-
14
-
-
84875851903
-
Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells)
-
3608459 1:CAS:528:DC%2BC3sXkslSktLs%3D 23378628
-
Kazmi F, Hensley T, Pope C, Funk RS, Loewen GJ, Buckley DB, et al. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells). Drug Metab Dispos. 2013;41(4):897-905.
-
(2013)
Drug Metab Dispos
, vol.41
, Issue.4
, pp. 897-905
-
-
Kazmi, F.1
Hensley, T.2
Pope, C.3
Funk, R.S.4
Loewen, G.J.5
Buckley, D.B.6
-
15
-
-
3542992044
-
Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60
-
1:CAS:528:DC%2BD2cXmtVChsLg%3D 15181006
-
Duvvuri M, Gong Y, Chatterji D, Krise JP. Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60. J Biol Chem. 2004;279(31):32367-72.
-
(2004)
J Biol Chem
, vol.279
, Issue.31
, pp. 32367-32372
-
-
Duvvuri, M.1
Gong, Y.2
Chatterji, D.3
Krise, J.P.4
-
16
-
-
1642462152
-
Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99
-
1:CAS:528:DC%2BD2cXisFyltrk%3D 15051542
-
Lemieux B, Percival MD, Falgueyret JP. Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99. Anal Biochem. 2004;327(2):247-51.
-
(2004)
Anal Biochem
, vol.327
, Issue.2
, pp. 247-251
-
-
Lemieux, B.1
Percival, M.D.2
Falgueyret, J.P.3
-
17
-
-
0023391094
-
From growth factor dependence to growth factor responsiveness: The genesis of an alveolar macrophage cell line
-
1:CAS:528:DyaL1cXht1Ch 3497918
-
Helmke RJ, Boyd RL, German VF, Mangos JA. From growth factor dependence to growth factor responsiveness: the genesis of an alveolar macrophage cell line. In Vitro Cell Dev Biol. 1987;23(8):567-74.
-
(1987)
Vitro Cell Dev Biol
, vol.23
, Issue.8
, pp. 567-574
-
-
Helmke, R.J.1
Boyd, R.L.2
German, V.F.3
Mangos, J.A.4
-
18
-
-
0024598765
-
A continuous alveolar macrophage cell line: Comparisons with freshly derived alveolar macrophages
-
1:STN:280:DyaL1M7it12ntw%3D%3D 2914814
-
Helmke RJ, German VF, Mangos JA. A continuous alveolar macrophage cell line: comparisons with freshly derived alveolar macrophages. In Vitro Cell Dev Biol. 1989;25(1):44-8.
-
(1989)
In Vitro Cell Dev Biol
, vol.25
, Issue.1
, pp. 44-48
-
-
Helmke, R.J.1
German, V.F.2
Mangos, J.A.3
-
19
-
-
74149094512
-
The behavior of PLGA microspheres containing rifampicin in alveolar macrophages
-
1:CAS:528:DC%2BC3cXotlShuw%3D%3D 19954935
-
Onoshita T, Shimizu Y, Yamaya N, Miyazaki M, Yokoyama M, Fujiwara N, et al. The behavior of PLGA microspheres containing rifampicin in alveolar macrophages. Colloids Surf B: Biointerfaces. 2010;76(1):151-7.
-
(2010)
Colloids Surf B: Biointerfaces
, vol.76
, Issue.1
, pp. 151-157
-
-
Onoshita, T.1
Shimizu, Y.2
Yamaya, N.3
Miyazaki, M.4
Yokoyama, M.5
Fujiwara, N.6
-
20
-
-
71449110365
-
Distribution characteristics of telithromycin, a novel ketolide antimicrobial agent applied for treatment of respiratory infection, in lung epithelial lining fluid and alveolar macrophages
-
1:CAS:528:DC%2BD1MXhs1WhtrbL 19881252
-
Togami K, Chono S, Seki T, Morimoto K. Distribution characteristics of telithromycin, a novel ketolide antimicrobial agent applied for treatment of respiratory infection, in lung epithelial lining fluid and alveolar macrophages. Drug Metab Pharmacokinet. 2009;24(5):411-7.
-
(2009)
Drug Metab Pharmacokinet
, vol.24
, Issue.5
, pp. 411-417
-
-
Togami, K.1
Chono, S.2
Seki, T.3
Morimoto, K.4
-
21
-
-
15444352573
-
Quantitative structure-activity relationships among macrolide antibacterial agents: In vitro and in vivo potency against Pasteurella multocida
-
1:CAS:528:DyaK2sXitlWisr4%3D 9135031
-
McFarland JW, Berger CM, Froshauer SA, Hayashi SF, Hecker SJ, Jaynes BH, et al. Quantitative structure-activity relationships among macrolide antibacterial agents: in vitro and in vivo potency against Pasteurella multocida. J Med Chem. 1997;40(9):1340-6.
-
(1997)
J Med Chem
, vol.40
, Issue.9
, pp. 1340-1346
-
-
McFarland, J.W.1
Berger, C.M.2
Froshauer, S.A.3
Hayashi, S.F.4
Hecker, S.J.5
Jaynes, B.H.6
-
22
-
-
0033846711
-
Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs
-
1:CAS:528:DC%2BD3cXmtFCntLo%3D 10945864
-
Ishizaki J, Yokogawa K, Ichimura F, Ohkuma S. Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs. J Pharmacol Exp Ther. 2000;294(3):1088-98.
-
(2000)
J Pharmacol Exp Ther
, vol.294
, Issue.3
, pp. 1088-1098
-
-
Ishizaki, J.1
Yokogawa, K.2
Ichimura, F.3
Ohkuma, S.4
-
23
-
-
0036891948
-
The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties
-
1:CAS:528:DC%2BD38XptVyisbg%3D 12433825
-
Austin RP, Barton P, Cockroft SL, Wenlock MC, Riley RJ. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos. 2002;30(12):1497-503.
-
(2002)
Drug Metab Dispos
, vol.30
, Issue.12
, pp. 1497-1503
-
-
Austin, R.P.1
Barton, P.2
Cockroft, S.L.3
Wenlock, M.C.4
Riley, R.J.5
-
24
-
-
33846126544
-
Potentiometric and spectrophotometric pKa determination of water-insoluble compounds: Validation study in a new cosolvent system
-
17386575
-
Volgyi G, Ruiz R, Box K, Comer J, Bosch E, Takacs-Novak K. Potentiometric and spectrophotometric pKa determination of water-insoluble compounds: validation study in a new cosolvent system. Anal Chim Acta. 2007;583(2):418-28.
-
(2007)
Anal Chim Acta
, vol.583
, Issue.2
, pp. 418-428
-
-
Volgyi, G.1
Ruiz, R.2
Box, K.3
Comer, J.4
Bosch, E.5
Takacs-Novak, K.6
-
25
-
-
0024380813
-
On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration
-
1:STN:280:DyaK383hs1ClsQ%3D%3D 2577691
-
Jeppsson AB, Lofdahl CG, Waldeck B, Widmark E. On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration. Pulm Pharmacol. 1989;2(2):81-5.
-
(1989)
Pulm Pharmacol
, vol.2
, Issue.2
, pp. 81-85
-
-
Jeppsson, A.B.1
Lofdahl, C.G.2
Waldeck, B.3
Widmark, E.4
-
26
-
-
0028966069
-
Lipophilicity of amphoteric molecules expressed by the true partition coefficient
-
Takács-Novák K, Józan M, Szász G. Lipophilicity of amphoteric molecules expressed by the true partition coefficient. Int J Pharm. 1995;113(1):47-55.
-
(1995)
Int J Pharm
, vol.113
, Issue.1
, pp. 47-55
-
-
Takács-Novák, K.1
Józan, M.2
Szász, G.3
-
27
-
-
0032480901
-
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach
-
1:CAS:528:DyaK1cXntFKltLw%3D 9836611
-
Winiwarter S, Bonham NM, Ax F, Hallberg A, Lennernas H, Karlen A. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J Med Chem. 1998;41(25):4939-49.
-
(1998)
J Med Chem
, vol.41
, Issue.25
, pp. 4939-4949
-
-
Winiwarter, S.1
Bonham, N.M.2
Ax, F.3
Hallberg, A.4
Lennernas, H.5
Karlen, A.6
-
28
-
-
0037683435
-
Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography-mass spectrometry
-
1:CAS:528:DC%2BD3sXkt1Ors7k%3D
-
Kerns EH, Di L, Petusky S, Kleintop T, Huryn D, McConnell O, et al. Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2003;791(1-2):381-8.
-
(2003)
J Chromatogr B Anal Technol Biomed Life Sci
, vol.791
, Issue.1-2
, pp. 381-388
-
-
Kerns, E.H.1
Di, L.2
Petusky, S.3
Kleintop, T.4
Huryn, D.5
McConnell, O.6
-
29
-
-
0017366064
-
Studies of binding C3-substitute rifamycins to human and bovine serum albumin
-
1:CAS:528:DyaE2sXltFWhtb0%3D
-
Assandri A, Perazzi A, Berti M. Studies of binding C3-substitute rifamycins to human and bovine serum albumin. J Antibiot (Tokyo). 1977;30(5):409-15.
-
(1977)
J Antibiot (Tokyo)
, vol.30
, Issue.5
, pp. 409-415
-
-
Assandri, A.1
Perazzi, A.2
Berti, M.3
-
30
-
-
28044443143
-
Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms
-
1:CAS:528:DC%2BD2MXht1amu7%2FL 16059874
-
Agrawal S, Panchagnula R. Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms. Biopharm Drug Dispos. 2005;26(8):321-34.
-
(2005)
Biopharm Drug Dispos
, vol.26
, Issue.8
, pp. 321-334
-
-
Agrawal, S.1
Panchagnula, R.2
-
31
-
-
84858673980
-
Simultaneous assessment of uptake and metabolism in rat hepatocytes: A comprehensive mechanistic model
-
3310695 22190645
-
Ménochet K, Kenworthy KE, Houston JB, Galetin A. Simultaneous assessment of uptake and metabolism in rat hepatocytes: a comprehensive mechanistic model. J Pharmacol Exp Ther. 2012;341(1):2-15.
-
(2012)
J Pharmacol Exp Ther
, vol.341
, Issue.1
, pp. 2-15
-
-
Ménochet, K.1
Kenworthy, K.E.2
Houston, J.B.3
Galetin, A.4
-
32
-
-
84867064670
-
An immortalised astrocyte cell line maintains the in vivo phenotype of a primary porcine in vitro blood-brain barrier model
-
1:CAS:528:DC%2BC38XhsValsrfJ 22940232
-
Cantrill CA, Skinner RA, Rothwell NJ, Penny JI. An immortalised astrocyte cell line maintains the in vivo phenotype of a primary porcine in vitro blood-brain barrier model. Brain Res. 2012;1479:17-30.
-
(2012)
Brain Res
, vol.1479
, pp. 17-30
-
-
Cantrill, C.A.1
Skinner, R.A.2
Rothwell, N.J.3
Penny, J.I.4
-
33
-
-
84868708283
-
Multiple cancer testis antigens function to support tumor cell mitotic fidelity
-
3457335 1:CAS:528:DC%2BC38XhsV2it7rN 22869527
-
Cappell KM, Sinnott R, Taus P, Maxfield K, Scarbrough M, Whitehurst AW. Multiple cancer testis antigens function to support tumor cell mitotic fidelity. Mol Cell Biol. 2012;32(20):4131-40.
-
(2012)
Mol Cell Biol
, vol.32
, Issue.20
, pp. 4131-4140
-
-
Cappell, K.M.1
Sinnott, R.2
Taus, P.3
Maxfield, K.4
Scarbrough, M.5
Whitehurst, A.W.6
-
34
-
-
0031047587
-
Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs
-
1:CAS:528:DyaK2sXhtlOnt70%3D 9060036
-
Daniel WA, Wojcikowski J. Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs. Pharmacol Toxicol. 1997;80(2):62-8.
-
(1997)
Pharmacol Toxicol
, vol.80
, Issue.2
, pp. 62-68
-
-
Daniel, W.A.1
Wojcikowski, J.2
-
35
-
-
2642714342
-
Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents
-
392768 1:CAS:528:DyaE1cXlvFegsbY%3D 28524
-
Ohkuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A. 1978;75(7):3327-31.
-
(1978)
Proc Natl Acad Sci U S A
, vol.75
, Issue.7
, pp. 3327-3331
-
-
Ohkuma, S.1
Poole, B.2
-
36
-
-
80053161024
-
Kinetic characterization of rat hepatic uptake of 16 actively transported drugs
-
1:CAS:528:DC%2BC3MXhs1ekurnI 21730030
-
Yabe Y, Galetin A, Houston JB. Kinetic characterization of rat hepatic uptake of 16 actively transported drugs. Drug Metab Dispos. 2011;39(10):1808-14.
-
(2011)
Drug Metab Dispos
, vol.39
, Issue.10
, pp. 1808-1814
-
-
Yabe, Y.1
Galetin, A.2
Houston, J.B.3
-
37
-
-
33751100417
-
Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance
-
1:CAS:528:DC%2BD28XhtFGqt7jI 16882765
-
Hallifax D, Houston JB. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance. Drug Metab Dispos. 2006;34(11):1829-36.
-
(2006)
Drug Metab Dispos
, vol.34
, Issue.11
, pp. 1829-1836
-
-
Hallifax, D.1
Houston, J.B.2
-
38
-
-
77949533787
-
Intracellular pharmacokinetics of telithromycin, a ketolide antibiotic, in alveolar macrophages
-
1:CAS:528:DC%2BC3cXhsVOkuro%3D 20723001
-
Togami K, Chono S, Seki T, Morimoto K. Intracellular pharmacokinetics of telithromycin, a ketolide antibiotic, in alveolar macrophages. J Pharm Pharmacol. 2010;62(1):71-5.
-
(2010)
J Pharm Pharmacol
, vol.62
, Issue.1
, pp. 71-75
-
-
Togami, K.1
Chono, S.2
Seki, T.3
Morimoto, K.4
-
39
-
-
34547163963
-
Saturable uptake of lipophilic amine drugs into isolated hepatocytes: Mechanisms and consequences for quantitative clearance prediction
-
1:CAS:528:DC%2BD2sXosVKqtbs%3D 17470525
-
Hallifax D, Houston JB. Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction. Drug Metab Dispos. 2007;35(8):1325-32.
-
(2007)
Drug Metab Dispos
, vol.35
, Issue.8
, pp. 1325-1332
-
-
Hallifax, D.1
Houston, J.B.2
-
40
-
-
0022657943
-
Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro
-
1:CAS:528:DyaL28XotF2ktA%3D%3D 3941401
-
Heyneman CA, Reasor MJ. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro. J Pharmacol Exp Ther. 1986;236(1):60-4.
-
(1986)
J Pharmacol Exp Ther
, vol.236
, Issue.1
, pp. 60-64
-
-
Heyneman, C.A.1
Reasor, M.J.2
-
41
-
-
0025721930
-
Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture
-
1:CAS:528:DyaK38Xns1SrsQ%3D%3D 1768272
-
Antonini JM, Reasor MJ. Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture. Biochem Pharmacol. 1991;42(Supplement 1):S151-6.
-
(1991)
Biochem Pharmacol
, vol.42
, Issue.SUPPLEMENT 1
, pp. S151-S156
-
-
Antonini, J.M.1
Reasor, M.J.2
-
42
-
-
0022631107
-
Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels
-
1:CAS:528:DyaL28XotF2ktw%3D%3D 3941400
-
Heyneman CA, Reasor MJ. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels. J Pharmacol Exp Ther. 1986;236(1):55-9.
-
(1986)
J Pharmacol Exp Ther
, vol.236
, Issue.1
, pp. 55-59
-
-
Heyneman, C.A.1
Reasor, M.J.2
-
43
-
-
0015417305
-
Accumulation of 14 C-imipramine in isolated perfused rat lungs
-
1:CAS:528:DyaE3sXht1c%3D 5080029
-
Junod AF. Accumulation of 14 C-imipramine in isolated perfused rat lungs. J Pharmacol Exp Ther. 1972;183(1):182-7.
-
(1972)
J Pharmacol Exp Ther
, vol.183
, Issue.1
, pp. 182-187
-
-
Junod, A.F.1
-
44
-
-
0019486892
-
Species and dose differences in the accumulation of imipramine by mammalian lungs
-
1:CAS:528:DyaL3MXkvFSktbY%3D 6114830
-
Drew R, Siddik ZH, Mimnaugh EG, Gram TE. Species and dose differences in the accumulation of imipramine by mammalian lungs. Drug Metab Dispos. 1981;9(4):322-6.
-
(1981)
Drug Metab Dispos
, vol.9
, Issue.4
, pp. 322-326
-
-
Drew, R.1
Siddik, Z.H.2
Mimnaugh, E.G.3
Gram, T.E.4
-
45
-
-
0345019898
-
Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature
-
1:CAS:528:DyaK2sXnvVSgtbw%3D 9443599
-
Frezard F, Garnier-Suillerot A. Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature. Biochim Biophys Acta. 1998;1389(1):13-22.
-
(1998)
Biochim Biophys Acta
, vol.1389
, Issue.1
, pp. 13-22
-
-
Frezard, F.1
Garnier-Suillerot, A.2
-
46
-
-
0036293982
-
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
-
1:CAS:528:DC%2BD38Xlslyru7c%3D 12085361
-
Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology. 2002;36(1):164-72.
-
(2002)
Hepatology
, vol.36
, Issue.1
, pp. 164-172
-
-
Vavricka, S.R.1
Van Montfoort, J.2
Ha, H.R.3
Meier, P.J.4
Fattinger, K.5
-
47
-
-
79952320380
-
Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes
-
1:CAS:528:DC%2BC38XnvFCluw%3D%3D 21372390
-
Yamaguchi H, Takeuchi T, Okada M, Kobayashi M, Unno M, Abe T, et al. Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes. Biol Pharm Bull. 2011;34(3):389-95.
-
(2011)
Biol Pharm Bull
, vol.34
, Issue.3
, pp. 389-395
-
-
Yamaguchi, H.1
Takeuchi, T.2
Okada, M.3
Kobayashi, M.4
Unno, M.5
Abe, T.6
-
48
-
-
76249120508
-
Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: Implications for carrier-mediated pulmonary absorption
-
1:CAS:528:DC%2BC3cXhtFGgtA%3D%3D 20020740
-
Nakamura T, Nakanishi T, Haruta T, Shirasaka Y, Keogh JP, Tamai I. Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption. Mol Pharm. 2010;7(1):187-95.
-
(2010)
Mol Pharm
, vol.7
, Issue.1
, pp. 187-195
-
-
Nakamura, T.1
Nakanishi, T.2
Haruta, T.3
Shirasaka, Y.4
Keogh, J.P.5
Tamai, I.6
-
49
-
-
78650755420
-
Organic cation transporter-mediated renal secretion of ipratropium and tiotropium in rats and humans
-
1:CAS:528:DC%2BC3MXls1elsQ%3D%3D 20962061
-
Nakanishi T, Haruta T, Shirasaka Y, Tamai I. Organic cation transporter-mediated renal secretion of ipratropium and tiotropium in rats and humans. Drug Metab Dispos. 2011;39(1):117-22.
-
(2011)
Drug Metab Dispos
, vol.39
, Issue.1
, pp. 117-122
-
-
Nakanishi, T.1
Haruta, T.2
Shirasaka, Y.3
Tamai, I.4
-
50
-
-
35648938725
-
The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells
-
1:CAS:528:DC%2BD2sXht1Kkur%2FJ 17920670
-
Horvath G, Mendes ES, Schmid N, Schmid A, Conner GE, Salathe M, et al. The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. J Allergy Clin Immunol. 2007;120(5):1103-9.
-
(2007)
J Allergy Clin Immunol
, vol.120
, Issue.5
, pp. 1103-1109
-
-
Horvath, G.1
Mendes, E.S.2
Schmid, N.3
Schmid, A.4
Conner, G.E.5
Salathe, M.6
-
51
-
-
33846100266
-
Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway
-
1899308 1:CAS:528:DC%2BD2sXhtFSlsL8%3D 16917073
-
Horvath G, Schmid N, Fragoso MA, Schmid A, Conner GE, Salathe M, et al. Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. Am J Respir Cell Mol Biol. 2007;36(1):53-60.
-
(2007)
Am J Respir Cell Mol Biol
, vol.36
, Issue.1
, pp. 53-60
-
-
Horvath, G.1
Schmid, N.2
Fragoso, M.A.3
Schmid, A.4
Conner, G.E.5
Salathe, M.6
-
52
-
-
0029896233
-
Contribution of lysosomes to the subcellular distribution of basic drugs in the rat liver
-
1:CAS:528:DyaK28Xjs1yrt7g%3D 8792430
-
Ishizaki J, Yokogawa K, Hirano M, Nakashima E, Sai Y, Ohkuma S, et al. Contribution of lysosomes to the subcellular distribution of basic drugs in the rat liver. Pharm Res. 1996;13(6):902-6.
-
(1996)
Pharm Res
, vol.13
, Issue.6
, pp. 902-906
-
-
Ishizaki, J.1
Yokogawa, K.2
Hirano, M.3
Nakashima, E.4
Sai, Y.5
Ohkuma, S.6
-
53
-
-
0023719056
-
Types of interaction of amphiphilic drugs with phospholipid vesicles
-
1:CAS:528:DyaL1cXkvVKgs7s%3D 3392651
-
Joshi UM, Kodavanti PR, Coudert B, Dwyer TM, Mehendale HM. Types of interaction of amphiphilic drugs with phospholipid vesicles. J Pharmacol Exp Ther. 1988;246(1):150-7.
-
(1988)
J Pharmacol Exp Ther
, vol.246
, Issue.1
, pp. 150-157
-
-
Joshi, U.M.1
Kodavanti, P.R.2
Coudert, B.3
Dwyer, T.M.4
Mehendale, H.M.5
-
54
-
-
2942544477
-
Binding of imipramine to phospholipid bilayers using radioligand binding assay
-
1:CAS:528:DC%2BD2cXlvVenurg%3D 15270130
-
Fisar Z, Fuksova K, Velenovska M. Binding of imipramine to phospholipid bilayers using radioligand binding assay. Gen Physiol Biophys. 2004;23(1):77-99.
-
(2004)
Gen Physiol Biophys
, vol.23
, Issue.1
, pp. 77-99
-
-
Fisar, Z.1
Fuksova, K.2
Velenovska, M.3
-
55
-
-
79952037605
-
A high content screening assay for identifying lysosomotropic compounds
-
1:CAS:528:DC%2BC3MXjsFahsb4%3D 21184822
-
Nadanaciva S, Lu S, Gebhard DF, Jessen BA, Pennie WD, Will Y. A high content screening assay for identifying lysosomotropic compounds. Toxicol In Vitro. 2011;25(3):715-23.
-
(2011)
Toxicol in Vitro
, vol.25
, Issue.3
, pp. 715-723
-
-
Nadanaciva, S.1
Lu, S.2
Gebhard, D.F.3
Jessen, B.A.4
Pennie, W.D.5
Will, Y.6
-
56
-
-
84855856561
-
In silico assay for assessing phospholipidosis potential of small druglike molecules: Training, validation, and refinement using several data sets
-
1:CAS:528:DC%2BC3MXhsFejtbjF 22122484
-
Fischer H, Atzpodien EA, Csato M, Doessegger L, Lenz B, Schmitt G, et al. In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets. J Med Chem. 2012;55(1):126-39.
-
(2012)
J Med Chem
, vol.55
, Issue.1
, pp. 126-139
-
-
Fischer, H.1
Atzpodien, E.A.2
Csato, M.3
Doessegger, L.4
Lenz, B.5
Schmitt, G.6
-
57
-
-
84907476662
-
Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1
-
25106415
-
Higgins JW, Ke AB, Zamek-Gliszczynski MJ. Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1. Drug Metab Dispos. 2014;42(11):1780-4.
-
(2014)
Drug Metab Dispos
, vol.42
, Issue.11
, pp. 1780-1784
-
-
Higgins, J.W.1
Ke, A.B.2
Zamek-Gliszczynski, M.J.3
-
58
-
-
84859910816
-
Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data
-
1:CAS:528:DC%2BC38Xmt1KnsrY%3D 22344703
-
Jones HM, Barton HA, Lai Y, Bi YA, Kimoto E, Kempshall S, et al. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data. Drug Metab Dispos. 2012;40(5):1007-17.
-
(2012)
Drug Metab Dispos
, vol.40
, Issue.5
, pp. 1007-1017
-
-
Jones, H.M.1
Barton, H.A.2
Lai, Y.3
Bi, Y.A.4
Kimoto, E.5
Kempshall, S.6
-
59
-
-
71949116668
-
Mechanistic modeling of hepatic transport from cells to whole body: Application to napsagatran and fexofenadine
-
1:CAS:528:DC%2BD1MXhtFynsbvK 19739673
-
Poirier A, Funk C, Scherrmann JM, Lave T. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine. Mol Pharm. 2009;6(6):1716-33.
-
(2009)
Mol Pharm
, vol.6
, Issue.6
, pp. 1716-1733
-
-
Poirier, A.1
Funk, C.2
Scherrmann, J.M.3
Lave, T.4
-
60
-
-
59649130318
-
Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans
-
1:CAS:528:DC%2BD1MXhs1Kgs7w%3D 19001154
-
Watanabe T, Kusuhara H, Maeda K, Shitara Y, Sugiyama Y. Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther. 2009;328(2):652-62.
-
(2009)
J Pharmacol Exp Ther
, vol.328
, Issue.2
, pp. 652-662
-
-
Watanabe, T.1
Kusuhara, H.2
Maeda, K.3
Shitara, Y.4
Sugiyama, Y.5
-
61
-
-
84879416924
-
ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans
-
3898877 1:CAS:528:DC%2BC3sXpvVOrtbc%3D 23588311
-
Zamek-Gliszczynski MJ, Lee CA, Poirier A, Bentz J, Chu X, Ellens H, et al. ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans. Clin Pharmacol Ther. 2013;94(1):64-79.
-
(2013)
Clin Pharmacol Ther
, vol.94
, Issue.1
, pp. 64-79
-
-
Zamek-Gliszczynski, M.J.1
Lee, C.A.2
Poirier, A.3
Bentz, J.4
Chu, X.5
Ellens, H.6
|